"AI-Powered CGM Revolutionizes Diabetes Management, Offers New Hope to Millions"
London, UK - November 25, 2022 - The National Health Service (NHS) England has hailed the advancements in Continuous Glucose Monitoring (CGM) as a game-changer in diabetes management, transforming the lives of millions of individuals worldwide. CGM technology has made it possible for people with diabetes to gain real-time insights into their glucose levels, making better health decisions and reducing the risk of complications.
According to Professor Partha Kar, National Specialty Advisor on Diabetes for NHS England,CGM devices have revolutionized diabetes care by providing a continuous picture of glucose levels, including current status, eight-hour trend, and directional arrow indicating future trajectory. This innovative technology gives both patients and doctors a wealth of information to inform treatment decisions and lifestyle modifications.
One of the most significant benefits of CGM is its ability to provide real-time data, allowing individuals with diabetes to take action when their blood glucose levels are high or low. Professor Kar noted that this real-time feedback enables people to better understand how their body responds to various factors such as medication, exercise, and diet, thereby minimizing extreme changes.
The introduction of Time in Range (TIR), a new statistic introduced by CGM systems, has also significantly improved diabetes management. TIR measures the proportion of time that blood glucose levels remain within a particular range, reducing the risk of complications such as nerve damage, retinal disease, and heart disease. Studies have shown that maintaining a TIR of greater than 80% can significantly reduce the risk of infections, ICU treatment, and other complications.
In addition to its clinical benefits, CGM technology has also made diabetic care more convenient and accessible. Unlike traditional fingerstick testing, which requires frequent blood draws, CGM devices offer a continuous and effortless monitoring solution, freeing individuals from the discomfort of routine finger stickers.
"Millions of people are being freed from the inconvenience of routine finger sticks by today's CGM devices," said Professor Kar. "Advances in digital health technologies like CGM have transformed diabetes care greatly, particularly for patients living with insulin delivery systems and other management innovations."
The NHS English Diabetes Care Programme has welcomed the role that CGM technology plays in improving diabetes outcomes and reducing complications. With its commitment to advancing healthcare innovation, the program will continue to support the implementation of CGM technology in clinical settings nationwide.
In a bid to promote awareness about digital health technologies, Professor Kar emphasized the importance of education and literacy among patients with diabetes, doctors, and other healthcare professionals. "With correct usage and monitoring by healthcare providers, individuals can make better health decisions, enabling them to live more active, comfortable, and healthy lives."